Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

MMWR Morbidity and Mortality Weekly Report

Topics

Medicine

Epidemiology

Immunology

Internal Medicine

Health

Show all topics

DOI

10.15585/mmwr.mm7349a2

Other Formats

PDF